Ownership history in WOLVERINE TRADING, LLC · 32 quarters on record
This page tracks every 13F SEC filing in which WOLVERINE TRADING, LLC reported a position in VANDA PHARMACEUTICALS INC (VNDA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q2 | ADDED | 11,417 | +1,417 | +14.2% | 0.00% | $55K | $4.72 |
| 2025 Q2 | REDUCED | 10,000 | -800 | -7.4% | 0.00% | $48K | $4.72 |
| 2025 Q1 | ADDED | 10,800 | +305 | +2.9% | 0.00% | $51K | $4.59 |
| 2024 Q4 | REDUCED | 10,495 | -905 | -7.9% | 0.00% | $50K | $4.79 |
| 2024 Q4 | REDUCED | 11,400 | -717 | -5.9% | 0.00% | $54K | $4.79 |
| 2024 Q3 | REDUCED | 12,117 | -2,883 | -19.2% | 0.00% | $57K | $4.69 |
| 2024 Q3 | ADDED | 15,000 | +4,000 | +36.4% | 0.00% | $70K | $4.69 |
| 2024 Q2 | REDUCED | 11,000 | -70,200 | -86.5% | 0.00% | $62K | $5.65 |
| 2024 Q2 | ADDED | 81,200 | +70,099 | +631.5% | 0.00% | $459K | $5.65 |
| 2023 Q4 | ADDED | 11,101 | +301 | +2.8% | 0.00% | $47K | $4.22 |
As of 2025 Q4 — sorted by position size